The Food and Drug Administration (FDA) of the United States has issued a warning that four common diabetes drugs may cause potentially life-threatening harm. Canaglflozin, sold by Janssen Pharmaceuticals as Invokana and Invokamet and dapagliflozin, sold by AstraZeneca as Farxiga and Xigudo XR are thought by the FDA to be more damaging to the kidneys than previously … [Read more...] about FDA Issues Kidney Warning for Four Diabetes Drugs
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Diabetic Kitchen